Drug recall
Red Blood Cells Leukocytes reduced
FDA recall event 34089 · Class II · Hemacare Corporation
Key facts
| Event ID | 34089 |
|---|---|
| Recall numbers | B-2557-13 |
| Recalling firm | Hemacare Corporation |
| Product type | Biologics |
| Products | Red Blood Cells Leukocytes reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood product, collected from a donor who tested reactive for the antibody to hepatitis B core antigen on two separate occasions, was distributed. |
| Initiation date | Feb 5, 2003 |
| Report date | Sep 25, 2013 |
| Termination date | Sep 13, 2013 |
| City | Van Nuys |
| State | CA |
| Country | United States |
| FEI number | 3004200746 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: